Integra LifeSciences Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range
July 26, 2017 6:05 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $282.2 million versus the consensus estimate of $283.7 million.
The company is tightening full-year 2017 revenue guidance to a new range of $1.125 billion to $1.140 billion,... More


